– Remote monitoring devices are an emerging and rapidly growing healthcare support system for doctors, and they’re already generating hundreds of millions in sales yearly for the company’s that develop them.
– Biotricity just launched their first device, a remote EKG monitor that sends data directly to a monitoring center and to a patient’s doctor to expedite heart disorder diagnosis. Company is ahead of schedule with first major cardiovascular center launching device last month, and sales to follow in coming months.
– Company will expand product portfolio with new device announcement in third quarter, another potential value driver in 2018 that could send stock higher. Comparisons to other companies suggest stock could be worth $9 to $14 in coming years as sales emerge.
The average investor probably isn’t aware of this under-the-radar …View the full post at: BTCY Could Be Worth $9+ as Medical Device Roll-Out Is Ahead Of Schedule …
Related Articles:
Big Cannabis Seeking Organic Options to Promote Quality Over Quantity
SenseiTrade Introduces Dollar-Based Investing, Enabling Real-World Investing in U.S. Equities
China’s Fertilizer Shortage Giving Global Producers a Boost
Will This Be The Next Commodity To Boom?
